$30.00
P41 PT141 10mg
P41 PT-141 10mg contains PT-141 (bremelanotide), a synthetic peptide that acts on melanocortin receptors. Bremelanotide is an FDA-approved prescription medication under the brand Vyleesi for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in certain premenopausal women.
Description
P41 PT-141 10mg contains PT-141 (bremelanotide), a synthetic peptide that acts on melanocortin receptors. Bremelanotide is an FDA-approved prescription medication under the brand Vyleesi for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in certain premenopausal women.
Key features
- Active ingredient: Bremelanotide (PT-141)
- Strength: 10mg
- Class: Melanocortin receptor agonist
- Mechanism: Acts on melanocortin receptors involved in sexual desire pathways
- Prescription status: Prescription medication for an FDA-approved indication
Customer benefits:
- Used for the treatment of acquired, generalized HSDD in eligible premenopausal women
- Works through melanocortin receptor pathways associated with sexual desire
- Provides a prescription treatment option for an approved sexual-health indication
Storage
| Before reconstitution: | After reconstitution: |
|---|---|
| – Store according to the manufacturer’s official labeling – Protect from excessive heat and direct light – Keep in the original packaging and out of reach of children |
– Follow the storage and handling instructions for the specific formulation – Do not use a product that has been improperly stored, contaminated, or visibly changed – Follow the prescribed administration instructions provided by a qualified healthcare professional |
Reviews
There are no reviews yet.